...
首页> 外文期刊>Acta Cardiologica >Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry
【24h】

Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

机译:在比利时新诊断的心房颤动患者抗凝治疗中的治疗模式:GARFIELF-AF注册表的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: AF, anticoagulation, NOACs, changing patterns of prescription. Methods: We describe baseline data and treatment patterns of patients recruited in Belgium in the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). Recruitment began when novel oral anticoagulants (NOACs) were introduced and provides a unique picture of changing treatment patterns over time. 1713 patients with a new ( = 2), anticoagulants were used in 84.3%, leaving 15.7% unprotected. In low risk patients (CHA(2)DS(2)-VASc 0-1) anticoagulants were overused (58.7%). Factor Xa inhibitors were used more frequently than direct thrombin inhibitors. Conclusion: Guideline adherence on stroke prevention was higher in Belgium than in the rest of Europe, and increased over time. NOAC use in Belgium was the highest of Europe at the study start, with many countries catching up later. Possible reasons are discussed.
机译:背景:AF,抗凝,诺卡克,转换模式变化。 方法:我们介绍在全球抗凝血登记处招募的患者的基线数据和治疗模式在田间颤动(Garfield-AF)中的全球抗凝血登记处。 在引入新的口腔抗凝血剂(NOACS)时,招聘开始并在随着时间的推移随着时间的推移提供改变治疗模式的独特画面。 1713名患有新(= 2)的患者,抗凝血剂以84.3%用于84.3%,未受保护15.7%。 在低风险患者(CHA(2)DS(2)-vasc 0-1)抗凝剂过度使用(58.7%)。 因子XA抑制剂比直接凝血酶抑制剂更频繁地使用。 结论:比利时预防卒中预防的准则遵守比欧洲其他地区更高,并随着时间的推移而增加。 比利时的Noac使用是研究开始的最高欧洲,许多国家以后追赶。 可能的原因讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号